Best IDSA Podcasts (2025)

1
110. The yeasts: Candida part 3, C. auris and Candida resistance 56:16

3d ago56:16

56:16

The conclusion of the Candida trilogy focuses on the rise of the Lord of the Candida resistance mechanisms: C. auris. Alyssa and Callum are joined by returning guest Professor Tihana Bicanic to discuss the rise of C. auris. Here we highlight some resources for managing this difficult to treat Candida including the recent UKHSA updated guidelines. W…

1
109. The yeasts: Candida part 2, Candidaemia and invasive disease 44:46

9d ago44:46

44:46

Yes we've done a Candida episode, but what about SECOND Candida episode? This week in the second part of the Candida Trilogy Alyssa and Callum are joined by Professor Tihana Bicanic to discuss all things invasive Candidiasis. Listen in to hear about treatment and diagnosis of this important condition, as well as some areas of current research and t…

1
Gaslighting in ID and the Push for Fair Compensation 26:48

12d ago26:48

26:48

ID physicians Priya Nori, MD, FSHEA, FIDSA, and Gonzalo Bearman, MD, MPH, FACP, FSHEA, FIDSA, join Paul Sax, MD, FIDSA, to discuss challenges often faced by ID specialists, including gaslighting and uncompensated labor. The three discuss how physicians can advocate for themselves, set boundaries, and push for meaningful change within their institut…

1
108. The yeasts: Candida part 1, overview and superficial candidiasis 45:13

17d ago45:13

45:13

In this episode there will be puns where you yeast expect them... But more seriously, what does Candida albicans actually mean? What are yeasts anyway? How does this all relate to the Romans? These questions, and more, will be answered as Alyssa and Callum continue the Fungal series with this, the first in a 3-parter on all things Candida! In this …

1
A New Global Definition of Acute Respiratory Distress Syndrome 33:05

20d ago33:05

33:05

This episode originally aired on January 17th, 2024. Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, "A New Global Definition of Acute Respiratory Distress Syndrome."By American Thoracic Society

1
107. Staphylococcus aureus bacteraemia (SAB) - interpreting and applying the literature 35:44

1M ago35:44

35:44

What exciting times! Clinical trials into the management of SAB! SNAP publication on the horizon! But how do we interpret and apply the results of these trials to our patients? This week Jame and Callum are joined by Dr Clark Russell, Clinical Lecturer in Infectious Diseases to discuss: The difficulty in interpreting current clinical trials in SAB.…

1
Changing Course: A Doctor’s Journey from Family Medicine to Infectious Diseases 25:20

1M ago25:20

25:20

Infectious diseases fellow Sam Peterson, MD, shares her unique journey to ID with Buddy Creech, MD, MPH, FPIDS. The two explore the power of mentorship, the value of storytelling, and what it takes to inspire the next generation of ID specialists.By Infectious Diseases Society of America (IDSA)

1
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease 45:40

1M ago45:40

45:40

Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, "Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease."By American Thoracic Society

1
106. Fungal diagnostics part 2: biomarkers, serology and molecular 45:22

1M ago45:22

45:22

Callum and Alyssa are joined by Professor Malcolm Richardson to talk about all things fungal diagnostics. In this, part 1 of 2 on diagnostics we discuss the use of biomarkers such as beta-D-Glucan and galactomannan, as well as serology and molecular techniques. Notes for this episode can be found: here. Send us a text Support the show Questions, co…

1
Federal ACA Threats and How They Could Impact Access to HIV Care and Treatment 21:54

2M ago21:54

21:54

John Fangman, MD, discusses threats to the Affordable Care Act and how they could impact people with HIV with JoAnn Volk, MA, research professor, founder, and co-director of the Center on Health Insurance Reforms at Georgetown University’s McCourt School of Public Policy and Tim Horn, Director, Medication Access at NASTAD.…

1
105. Fungal Diagnostics part 1: Microscopy, Culture & Identification techniques 50:39

2M ago50:39

50:39

Callum and Alyssa are joined by Professor Malcolm Richardson to talk about all things fungal diagnostics. In this, part 1 of 2 on diagnostics we discuss the use of microscopy, histopathology and culture in diagnosing fungal infections. Notes for this episode can be found: here. Send us a text Support the show Questions, comments, suggestions to idi…

1
Navigating a Career in Infectious Diseases: A Guide for International Medical Graduates 21:49

2M ago21:49

21:49

Paul Sax, MD, FIDSA, is joined by infectious diseases physicians and international medical graduates, Vidya Sundareshan, MD, and Alfredo Mena Lora, MD, FIDSA, to discuss how international medical graduates (IMGs) can pursue a career in infectious diseases. The trio discuss visa options, job search strategies, and how political change could impact t…

1
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline 16:04

2M ago16:04

16:04

Dr. John Fleetham chats with Dr. Sonal Munsiff and Dr. Raquel Duarte about their article, "Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline."By American Thoracic Society

1
104. IDSA Difficult To Treat Gram negatives Guidance 2024 with Breakpoints podcast 1:18:41

2M ago1:18:41

1:18:41

IT'S A BREAKPOINTS BREAKOUT! Jame and Callum are joined by the drugnamic duo of Julie-Ann Justo & Erin McCreary from the Breakpoints podcast to delve into the IDSA DTR Gram negative Guidance. Show notes for this episode are here. Breakpoints podcast can be found here: https://breakpoints-sidp.org/ Lyrics: Tryin’ to use some drugs to kill these bugs…

1
Measles and the Rise of Vaccine Preventable Diseases 27:02

2M ago27:02

27:02

Paul Sax, MD, FIDSA, speaks with Adam Ratner, MD, MPH, Professor of Pediatrics and Microbiology at NYU Grossman School of Medicine and Director of the Division of Pediatric Infectious Diseases at Hassenfeld Children’s Hospital and Bellevue Hospital Center, about his book, "Booster Shots: The Urgent Lessons of Measles" and the rise of vaccine preven…

1
Using Isoniazid More Safely and More Effectively in Tuberculosis Treatment 34:40

2M ago34:40

34:40

Dr. John Fleetham chats with Dr. Paolo Denti, Dr. Elisa Ignatius, Dr. Jason Andrews, and Dr. Neil Schluger about two papers and an editorial published in AJRCCM discussing the use of isoniazid in treating patients with tuberculosis.By American Thoracic Society

1
103. Fungal infections overview and series intro 31:04

2M ago31:04

31:04

My my! Mycology? Join Callum and special co-host Alyssa for this, the first in the all new ID:IOTS Mycology Mega-series. Here we cover: What the British Society of Medical Mycology is and what they do Why we're doing this series on fungi The Global and UK Burden of fungal disease. The spectrum of fungal disease clinically, The taxonomy of these pat…

1
Why Medicaid Matters: Why Protecting Medicaid Matters for People with HIV 27:00

2M ago27:00

27:00

Anna Person, MD discusses threats to the Medicaid program and how they could impact people with HIV with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Amy Killelea, JD, Assistant Research Professor at the Georgetown University Center on…

1
A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea 23:59

3M ago23:59

23:59

Dr. John Fleetham chats with Dr. Hedner and Dr. Schmickl about their articles “A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea" and “Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?”By American Thoracic Society

1
102. AST: When there are NO breakpoints- how to use the EUCAST guidance document 14:50

3M ago14:50

14:50

So now, Loyal Listener, you know all about Susceptible, Sensitive at higher doses, Resistant, MICs, ECOFFs/ECVs and how to use the EUCAST breakpoints table.... But what about the wild-west of bug-drug combos where there are no breakpoints? Well in this episode, Jame and Callum talk through the EUCAST approach to this situation. Show notes for this …

1
Leveraging Analytics and Disease Forecasting in Public Health 25:40

3M ago25:40

25:40

IDSA Board Member Mati Hlatshwayo Davis, MD, MPH, FIDSA, discusses public health forecasting and response efforts with Lior Rennert, PhD, director of the Center for Public Health Modeling and Response at Clemson University, and Dylan George, PhD, director of CDC’s Center for Forecasting and Outbreak Analytics (CFA).…

1
101. AST: When there ARE breakpoints - how to use the EUCAST clinical breakpoints table 15:56

3M ago15:56

15:56

BREAKPOINTS. We all love them. S breakpoints... R breakpoints... dash, IE, NA... Wait, dash, IA, NA, Brackets?! LISTEN ON (and read the accompanying prep notes), and soon you'll know! In this episode Jame and Callum talk through the EUCAST breakpoints table and how to interpret it Show notes for this episode here Send us a text Support the show Que…

1
Progressive Early Interstitial Lung Abnormalities in Persons At-Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study and Big Things Have Small Beginnings: Clinical Implications of Early Interstitial ... 26:37

3M ago26:37

26:37

Dr. Mohleen Kang chats with Dr. Margaret Salisbury and Dr. Anna Podolanczuk about their articles, "Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study" and "Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease."…

1
A Pioneer for Public Health: Celebrating the Legacy of Former President Jimmy Carter 28:36

3M ago28:36

28:36

IDSA Board Member Mati Hlatshwayo Davis, MD, MPH, FIDSA, Former CDC Director Rochelle Walensky, MD, MPH, FIDSA, and VP of Health Programs at the Carter Center, Kashef Ijaz, MD, MPH, discuss the legacy of Former President Jimmy Carter, his work addressing neglected tropical diseases and the impact and value of public advocacy and political support f…

1
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement 23:36

3M ago23:36

23:36

Dr. John Fleetham chats with Dr. Yet Kor about her article, "Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement."By American Thoracic Society

1
100. AST: Rapid Identification and Molecular AST. The BCID2 & Vitek Reveal with BioMérieux 34:49

4M ago34:49

34:49

Jame is joined by Kate from BioMérieux as they take a deep dive into the BCID2 and the Vitek Reveal, 2 new devices used for rapid identification and antimicrobial susceptibility testing of blood culture isolates. Note: This episode was produced in collaboration with BioMérieux. An honorarium received from them will be donated directly to charitable…

1
Exploring Clinical Dilemmas in Infectious Diseases 23:29

4M ago23:29

23:29

Paul Sax, MD, FIDSA, is joined by Varun Phadke, MD, and Daniel Minter, MD, co-creators of CID's new series, "Clinical Dilemmas in Infectious Diseases," which guides readers through challenging clinical management decisions in infectious diseases. Click here to learn more about submitting to the Clinical Dilemmas in Infectious Diseases series. Click…

1
99. AST: Automated Identification & Sensitivities - the Vitek2 with BioMérieux 26:37

4M ago26:37

26:37

This week Jame is joined by Nick and Dal from BioMérieux as they take a deep dive into the Vitek2, one of the machines available for performing Automated Antimicrobial Susceptibility Testing. Note: This episode was produced in collaboration with BioMérieux. An honorarium received from them will be donated directly to charitable causes. Message from…

1
Man in the Mirror: How ID Can Lead Sustainability Efforts in Health Care 27:22

4M ago27:22

27:22

Buddy Creech, MD, MPH, FPIDS, is joined by Sustainabil-ID co-founders, Preeti Jaggi, MD, and Shreya Doshi, MD, to discuss how ID can address issues of sustainability.By Infectious Diseases Society of America (IDSA)

1
98. Meningitis Masterclass 1:07:20

5M ago1:07:20

1:07:20

Jame and Callum are joined by Dr Fiona McGill, lead author of the 2016 Joint Specialist Societies Meningitis Guidelines. Listen to hear an overview of the epidemiology, presentation, diagnosis and management of both bacterial and viral meningitis in the UK. Show notes for this episode here Send us a text Support the show Questions, comments, sugges…

1
President's Podcast: An update on respiratory illness season 19:05

5M ago19:05

19:05

IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP, discusses the 2024-2025 respiratory illness season with Brendan Jackson, MD, MPH, Director of the Office of Readiness, Response and Operations at the CDC National Center for Immunization and Respiratory Diseases. The IDSA Leadership Institute empowers infectious diseases and HIV practitioners to be f…

1
97. FIS 2024 part 3: Fungi, NTM, quinolones and others 20:06

5M ago20:06

20:06

HO HO HO, MERRY FISMAS!!! On the Third & Final Pod of FISmas these ID:IOTS have for you… 6 golden topics! Listen to hear about: 1. Personalised approach to invasive fungal infection 2. Agricultural anti-fungals and One Health 3. Candida auris 4. NTM standards of care 5. Narrative reporting 6. Fluoroquinolones and the MHRA warnings Jame and Callum a…

1
96. FIS 2024 part 2: Viruses 23:13

5M ago23:13

23:13

HO HO HO, MERRY FISMAS!!! On the Second Pod of FISmas these ID:IOTS have for you… an all-enveloping, capsidating update on the High Consequence Infectious Diseases, measles, RSV and other viruses that you ‘R naught’ going to want to skip! Jame and Callum attended the Federation of Infection Societies 2024 annual meeting in Liverpool; here they shar…

1
Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis and The Arousal Threshold: The ‘Weakest Link’ in OSA Pathogenesis? 37:26

6M ago37:26

37:26

Dr. John Fleetham chats with Dr. Ludovico Messineo and Dr. Simon Joosten about their articles "Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis" and "The Arousal Threshold: The ‘Weakest Link’ in OSA Pathogenesis."By American Thoracic Society

1
95. FIS 2024 part 1: AMR & Bacteria 28:42

6M ago28:42

28:42

HO HO HO, MERRY FISMAS!!! On the First Pod of FISmas these ID:IOTS have to you… a terrifying update on the Antibiotic Apocalypse! Jame and Callum attended the Federation of Infection Societies 2024 annual meeting in Liverpool; here they share their reflections on the sessions they attended on: Bacteria and Antimicrobial resistance. Episodes on viru…

1
From treatment of strep pharyngitis to clinical trials – ID hot takes for winter 24:24

6M ago24:24

24:24

From treatment of strep pharyngitis to clinical trials, ID physicians and long-time friends Buddy Creech, MD, MPH, FPIDS, Jason Newland, MD, MEd, FPIDS and Jeffrey Gerber, MD, PhD, give their hot takes.By Infectious Diseases Society of America (IDSA)

1
Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients 33:14

6M ago33:14

33:14

Dr. Michael Lanspa chats with Dr. Hannah Wunsch about her paper, "Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients."By American Thoracic Society

1
94. BSAC OPAT conference 2024 25:14

6M ago25:14

25:14

Jame regales Callum with tales of his online adventure to the BSAC OPAT conference. Listen in to hear some updates on: implementation of OVIVA; subcutaneous antibiotics; and the BSAC OPAT good practice guidelines Notes for this episode here. Send us a text Support the show Questions, comments, suggestions to [email protected] or on Bluesky…

Podcasts Worth a Listen

IDSA Podcasts

Podcasts Worth a Listen